CD163 and neoplasm: To the best of our knowledge, only a single study has examined the immunohistochemical expression of G-CSF in a reasonably large breast cancer cohort (548 cases), reporting a significant positive correlation between G-CSF expression and CD163+ tumour-associated macrophages [32].